Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 19;48(5):e20220064.
doi: 10.36416/1806-3756/e20220064. eCollection 2022.

Mesothelioma in a developing country: a retrospective analysis of the diagnostic process

[Article in English, Portuguese]
Paulo Henrique Peitl Gregório  1 , Ricardo Mingarini Terra  2 , Leonardo Pontual Lima  2 , Paulo Manuel Pêgo-Fernandes  1
Affiliations

Mesothelioma in a developing country: a retrospective analysis of the diagnostic process

[Article in English, Portuguese]
Paulo Henrique Peitl Gregório et al. J Bras Pneumol. .

Abstract
in English, Portuguese

Objective: To evaluate the process of diagnosing patients with malignant pleural mesothelioma (MPM) at a tertiary care hospital.

Methods: This was a retrospective study involving patients referred to a tertiary-care cancer center in Brazil between 2009 and 2020. The diagnostic process was divided into four steps: onset of symptoms, referral to a specialist visit, histopathological diagnosis, and beginning of treatment. The intervals between each phase and the factors for delays were evaluated. Data including clinical status, radiological examinations, staging, treatment modalities, and survival outcomes were collected.

Results: During the study period, 66 patients (mean age = 64 years) were diagnosed with MPM and underwent treatment. Only 27 (41%) of the patients had knowledge of prior exposure to asbestos. The median number of months (IQR) between the onset of symptoms and the first specialist visit, between the specialist visit and histopathological characterization, and between definite diagnosis and beginning of treatment was, respectively, 6.5 (2.0-11.4), 1.5 (0.6-2.1), and 1.7 (1.2-3.4). The knowledge of prior asbestos exposure was associated with a shorter time to referral to a specialist (median: 214 vs. 120 days; p = 0.04). A substantial number of nondiagnostic procedures and false-negative biopsy results (the majority of which involved the use of Cope needle biopsy) were found to be decisive factors for the length of waiting time. The mean overall survival was 11.9 months.

Conclusions: The unfamiliarity of health professionals with MPM and the patient's lack of knowledge of prior asbestos exposure were the major factors to cause a long time interval between the onset of symptoms and beginning of treatment. An overall survival shorter than 1 year is likely to have been due to the aforementioned delays.

Objetivo:: Avaliar o processo de diagnóstico de pacientes com mesotelioma pleural maligno (MPM) em um hospital terciário.

Métodos:: Estudo retrospectivo envolvendo pacientes encaminhados a um centro oncológico terciário no Brasil entre 2009 e 2020. O processo diagnóstico foi dividido em quatro etapas: início dos sintomas, encaminhamento para consulta especializada, diagnóstico histopatológico e início do tratamento. Foram avaliados os intervalos entre as etapas e os fatores de atraso. Os dados coletados incluíram estado clínico, exames radiológicos, estadiamento, modalidades de tratamento e resultados de sobrevida.

Resultados:: Durante o período do estudo, 66 pacientes (média de idade = 64 anos) foram diagnosticados com MPM e submetidos a tratamento. Apenas 27 (41%) dos pacientes tinham conhecimento de exposição prévia ao amianto. A mediana de meses (IIQ) entre o início dos sintomas e a primeira consulta especializada, entre a consulta especializada e a caracterização histopatológica e entre o diagnóstico definitivo e o início do tratamento foi, respectivamente, de 6,5 (2,0-11,4), 1,5 (0,6 -2,1) e 1,7 (1,2-3,4). Conhecimento de exposição prévia ao amianto associou-se a menor tempo para encaminhamento a um especialista (mediana: 214 vs. 120 dias; p = 0,04). O número substancial de procedimentos não diagnósticos e as biópsias falso-negativas (a maioria envolvendo o uso de biópsia com agulha de Cope) foram considerados fatores decisivos para o tempo de espera. A sobrevida global média foi de 11,9 meses.

Conclusões:: A falta de familiaridade dos profissionais de saúde com o MPM e o desconhecimento dos pacientes em relação à exposição prévia ao amianto foram os principais fatores que ocasionaram um longo intervalo de tempo entre o início dos sintomas e o início do tratamento. A sobrevida global inferior a 1 ano provavelmente se deve aos atrasos supracitados.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: None declared.

Figures

Figure 1
Figure 1. Timeline of the process of diagnosing patients with malignant pleural mesothelioma. mo: months.
Figure 2
Figure 2. Survival analysis of the patients included in the study (N = 66).
Figure 3
Figure 3. Survival analysis of the patients (N = 66) according to TNM staging.
See this image and copyright information in PMC

Comment in

References

    1. Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119(4):514–518. doi: 10.1289/ehp.1002845. - DOI - PMC - PubMed
    1. The United States Geological Survey (USGS). National Minerals Information Center . Minerals Yearbook. USGS; Reston, VA, USA: 2015. https://d9-wret.s3-us-west-2.amazonaws.com/assets/palladium/production/m...
    1. Pedra F. Mortalidade por mesotelioma no Brasil de 1980 a 2010. Rio de Janeiro: Escola Nacional de Saúde Pública Sergio Arouca; 2015.
    1. Ugolini D, Bonassi S, Cristaudo A, Leoncini G, Ratto GB, Neri M. Temporal trend, geographic distribution, and publication quality in asbestos research. Environ Sci Pollut Res Int. 2015;22(9):6957–6967. doi: 10.1007/s11356-014-3925-1. - DOI - PubMed
    1. Algranti E, Ramos-Bonilla JP, Terracini B, Santana VS, Comba P, Pasetto R. Prevention of Asbestos Exposure in Latin America within a Global Public Health Perspective. Ann Glob Health. 2019;85(1):49–49. doi: 10.5334/aogh.2341. - DOI - PMC - PubMed